Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation

NCT02051309 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02051309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02051309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2014
Completion date
November 30, 2020
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation